C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2011
05/19/2011	WO2011058108A1 Quinoline and quinoxaline derivatives as kinase inhibitors
05/19/2011	WO2011057984A1 Novel diazinylpyrazolyl compounds
05/19/2011	WO2011057973A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011	WO2011057960A1 Crystalline cdc7 inhibitor salts
05/19/2011	WO2011057956A1 Benzisoxazole analogs as glycogen synthase activators
05/19/2011	WO2011057706A2 Materials for electronic devices
05/19/2011	WO2011057701A1 Organic compounds for electroluminescent devices
05/19/2011	WO2011004972A3 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/19/2011	WO2011003065A3 Pyrazolopyrimidine jak inhibitor compounds and methods
05/19/2011	US20110118479 Branched Succinimide Dispersant Compounds and Methods of Making the Compounds
05/19/2011	US20110118477 Sunitinib and salts thereof and their polymorphs
05/19/2011	US20110118475 Chiral acyclic diaminocarbene ligands, precursors therefore and their use in organic synthesis reactions
05/19/2011	US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
05/19/2011	US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use
05/19/2011	US20110118296 Bis-Carbazole DNA Intercalating Agents for Antitumor Therapy
05/19/2011	US20110118289 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands
05/19/2011	US20110118283 Substituted Pyrrolidine-2-Carboxamides
05/19/2011	US20110118282 Soluble Guanylate Cyclase Activators
05/19/2011	US20110118280 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
05/19/2011	US20110118266 Derivatives of triazines and uracils, their preparation and their application in human therapeutics
05/19/2011	US20110118259 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/19/2011	US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors
05/19/2011	US20110118245 Raf kinase modulator compounds and methods of use thereof
05/19/2011	US20110118244 Factor xa inhibitors
05/19/2011	US20110118236 Heterocyclic compound
05/19/2011	US20110118235 Substituted benzoazepines as toll-like receptor modulators
05/19/2011	US20110118234 Urea Compounds as Gamma Secretase Modulators
05/19/2011	US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof
05/19/2011	US20110118232 Pyrimidine compounds and use thereof
05/19/2011	US20110117301 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
05/19/2011	US20110117081 Functionalized pyrrolidines and use thereof as iap inhibitors
05/19/2011	US20110117073 Protein Kinase Conjugates and Inhibitors
05/19/2011	US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
05/19/2011	US20110117015 Diagnostic Agents Selective Against Metalloproteases
05/19/2011	US20110115368 Arylamine compound and organic electroluminescent device
05/19/2011	DE102009053382A1 Materialien für elektronische Vorrichtungen Materials for electronic devices
05/19/2011	CA2789879A1 Dimeric smac mimetics
05/19/2011	CA2781541A1 Crystalline forms of bosentan salt and processes for their preparation
05/19/2011	CA2780892A1 Kinase inhibitors
05/19/2011	CA2780812A1 Hepatitis c virus inhibitors
05/19/2011	CA2780768A1 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
05/19/2011	CA2780568A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011	CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
05/19/2011	CA2779088A1 [1,5]-diazocin derivatives
05/18/2011	EP2322534A1 Antiviral nucleosides
05/18/2011	EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3
05/18/2011	EP2322511A1 Process for the production of Telmisartan
05/18/2011	EP2322510A2 8-substituted benzoazepines as toll-like receptor modulators
05/18/2011	EP2322506A1 Histamine H3 receptor agents, preparation and therapeutic uses
05/18/2011	EP2321301A1 New heterocyclic carboxamides for use as thrombin inhibitors
05/18/2011	EP2321298A2 Aurora kinase modulators and methods of use
05/18/2011	EP2321296A1 Substituted 5-aminopyrazoles and use thereof
05/18/2011	EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/18/2011	EP2321282A1 New benzimidazole derivatives
05/18/2011	EP2321281A2 Anti inflammatory compounds
05/18/2011	EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
05/18/2011	EP2321262A1 Insecticidal 4-phenyl-1h-pyrazoles
05/18/2011	EP2158194B1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
05/18/2011	EP2046779B1 Modulators of chemokine receptor activity, crystalline forms and process
05/18/2011	EP1943232B1 Squaric acid derivatives as inhibitors of histone deacetylase
05/18/2011	EP1467969B1 Dna minor groove binding compounds
05/18/2011	EP1373210B1 Heterocyclic diamide invertebrate pest control agents
05/18/2011	CN1720225B N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
05/18/2011	CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/18/2011	CN102066361A Heteroaryl-substituted bicyclic SMAC mimetics and the uses thereof
05/18/2011	CN102066354A Novel microbiocides
05/18/2011	CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors
05/18/2011	CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
05/18/2011	CN102066338A Inhibitors of protein kinases
05/18/2011	CN102066335A Substituted pyrimidin-5-carboxamides 281
05/18/2011	CN102066334A 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
05/18/2011	CN102066323A Novel estrogen receptor ligands
05/18/2011	CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011	CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists
05/18/2011	CN102066320A Aryl ketone as MRI
05/18/2011	CN102060849A Dual functional radiation damage preventing and treating medicaments
05/18/2011	CN102060848A Preparation and application of aromatic amine substituted pyrimidine derivatives
05/18/2011	CN102060847A New method for stereospecific synthesis of voriconazole intermediate
05/18/2011	CN102060806A Cytokine inhibitors
05/18/2011	CN102060792A 2'-aminochalcone-zole compounds, pyrazoline and cyclopropyl azole derivatives thereof and preparation method and applications of compounds
05/18/2011	CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof
05/18/2011	CN101386602B S-triazine derivates with white light and preparation method and application thereof
05/18/2011	CN101146530B 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension
05/18/2011	CN101092413B Hydrate of medicinal salt of Fasudil
05/18/2011	CN101052634B Anthranilamide pyridinureas as vegf receptor kinase inhibitors
05/17/2011	US7943788 Glucopyranoside compound
05/17/2011	US7943784 Methylation of 3-(5-(1-(pyrrolidinyl sulfonylmethyl)-1H-indolyl)ethane amine with formaldehyde and sodium borohydride; adding hydroxybenzoic acid; salt formation
05/17/2011	US7943774 Heterocyclyl-substituted thiazoles as crop protection agents
05/17/2011	US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases
05/17/2011	US7943767 Fused bicyclic mTOR inhibitors
05/17/2011	US7943647 Process for the preparation of tetrazole derivatives from organo aluminium azides
05/17/2011	US7943635 Farnesyl-protein transferase inhibitors
05/17/2011	US7943627 2,4-diaminopyrimidine derivatives
05/17/2011	US7943607 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
05/17/2011	US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
05/17/2011	CA2514267C Malonamide derivatives as gamma-secretase inhibitors
05/17/2011	CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/17/2011	CA2397194C Alpha v integrin receptor antagonists
05/12/2011	WO2011056652A1 Imidazole derivatives as ido inhibitors
05/12/2011	WO2011056645A2 Poly(propargyl-l-glutamate) and derivatives thereof

1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 626